![Christopher B Anderson, MD](http://dynl.mktgcdn.com/p/1gUKApbT2LVrv4vpcK2Qh1Nd0Whm7yDDxcyNvA3BueY/198x198.png)
![Christopher B Anderson, MD](http://dynl.mktgcdn.com/p/1gUKApbT2LVrv4vpcK2Qh1Nd0Whm7yDDxcyNvA3BueY/198x198.png)
Christopher B Anderson, MD
Locations and Appointments
NewYork-Presbyterian Allen Hospital
ColumbiaDoctors - 40 Saw Mill River Road
CUIMC/Herbert Irving Pavilion
GET AN EXPERT SECOND OPINION
Insurances Accepted
Please contact the doctor's office to verify that your insurance is accepted.
- AETNA
- Affinity Health Plan
- AgeWell
- Amerigroup of New Jersey
- CIGNA
- Emblem/GHI
- Emblem/Hip
- Empire Blue Cross Blue Shield Healthplus
- Empire Blue Cross/Blue Shield
- Fidelis Care
- Healthfirst
- Local 1199
- Magnacare (National)
- Medicare
- Multiplan
- MVP Health Care
- Quality Health Management
- RiverSpring
- UnitedHealthcare
- VNSNY CHOICE
- WellCare
- World Trade Center Health Plan
About Christopher B Anderson, MD
Christopher B. Anderson, MD, Associate Professor of Urology at CUMC, joined the Department of Urology in September 2015. He specializes in cancers of the bladder, prostate, kidney, testis and penis and performs both open and robotic surgeries. Dr. Anderson completed his medical degree from Northwestern University, completed his urology residency at Vanderbilt University, and then spent two years at Memorial Sloan Kettering Cancer Center as a fellow in urologic oncology. Following his residency, Dr. Anderson completed a urologic oncology fellowship at Memorial Sloan Kettering Cancer Center and obtained a Master of Public Health degree from Harvard University.
Dr. Anderson's research interests include factors that influence the quality of surgery, access to care for patients with bladder cancer, outcomes after robotic prostatectomy, and active surveillance strategies for men with prostate cancer. Dr. Anderson has published several peer-reviewed articles and was recognized as "Best Reviewer" in 2014 by The Journal of Urology and in 2016 by Cancer.
Dr. Anderson has clinical expertise in robotic prostatectomy for the treatment of prostate cancer, radical cystectomy with orthotopic neobladder for patients with bladder cancer, and partial nephrectomy for the treatment of kidney tumors. He also specializes in the multidisciplinary management of men with testicular cancer, including the use of primary and post-chemotherapy retroperitoneal lymph node dissection. He is currently the site leader for several clinical trials investigating the use of immunotherapy in patients with invasive and non-invasive bladder cancer.
Board Certifications
- Urology
Expertise
Adrenal Cancer
Bladder Cancer
Cystectomy
Cystoscopy
Kidney Cancer
Laparoscopic Nephrectomy
Neobladder
Nephrectomy
Partial Nephrectomy
Prostate Cancer
Retroperitoneal Lymph Node Dissection
Robotic Partial Nephrectomy
Robotic Prostatectomy
Robotic Surgery
Testicular Cancer
Urological Oncology
Education
Fellowship: Memorial Sloan Kettering Cancer Center
Medical School: Northwestern University - Feinberg School of Medicine
Residency: Vanderbilt University Medical Center
Titles & Positions
Associate Professor of Urology at CUMC
Hospital Affiliations
NewYork-Presbyterian / Columbia University Irving Medical Center
NewYork-Presbyterian / Weill Cornell Medical Center
Education
- Residency: Vanderbilt University Medical Center
- Medical School: Northwestern University - Feinberg School of Medicine
- Fellowship: Memorial Sloan Kettering Cancer Center
Titles & Positions
- Associate Professor of Urology at CUMC
Board Certifications
- Urology